CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch ...
CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, and Family Medicine Specialists (FMS), ...
CHICAGO, December 03, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-powered precision cardiovascular medicine company, today announced that the Centers for Medicare ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced that the American Medical Association (AMA) has ...
"We view this as a critical step toward expanding timely access and improving care for Medicare patients," said Meesha Dogan, PhD., CEO and co-founder of Cardio Diagnostics. "Many Medicare ...
Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Cardio Diagnostics CDIO, an artificial intelligence-powered precision ...
CHICAGO, July 08, 2025--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO), a precision cardiovascular medicine company with a pioneering technology at the intersection of epigenetics ...
Cardiovascular disease risk assessment is an evolving field with new research indicating that more recommendations tailored to and personalized for patients are possible. Pooled cohort equations ...
A meta-analysis of 44 longitudinal cohort studies finds that poor metabolic health raises cardiovascular risk more ...
Amid the death of Toluwanisings from suspected cardiac arrest, a medical doctor, Popoola Daniel, shared three medical tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results